Systematic review of oral cryotherapy for management of oral mucositis caused by cancer therapy

…, T Mori, A Osaguona, DS Weikel, S Elad… - Supportive Care in …, 2013 - Springer
Purpose This systematic review analyzed the strength of the literature and defined clinical
practice guidelines for the use of oral cryotherapy for the prevention and/or treatment of oral …

A novel bioassay model to determine clinically significant bisphosphonate levels

…, AR Salama, G Warburton, KJ Cullen, DS Weikel… - Supportive care in …, 2009 - Springer
Purpose Bisphosphonate-associated osteonecrosis (BON) is a recently recognized oral
complication of bisphosphonate (BP) therapy. Currently, research into the pathogenesis of BON …

Periodontal disease and oral microbial successions during myelosuppressive cancer chemotherapy

…, GE Minah, DE Peterson, DS Weikel… - Journal of clinical …, 1989 - Wiley Online Library
Factors contributing to the succession of opportunistic pathogens at oral sites, including the
periodontium, during myelosuppressive chemotherapy are poorly understood. This study …

Effect of granulocytopenia on oral microbial relationships in patients with acute leukemia

…, GE Minah, MA Reynolds, DS Weikel… - Oral Surgery, Oral …, 1990 - Elsevier
Risk for acute infection increases as granulocyte levels decrease secondary to
myelosuppressive chemotherapy in patients with acute nonlymphocytic leukemia (ANLL). Acute …

Incidence of fever following invasive oral interventions in the myelosuppressed cancer patient

DS Weikel, DE Peterson, LE Rubinstein… - Cancer …, 1989 - journals.lww.com
Oral complications in cancer patients with chemotherapy-induced myelosuppression
contribute to morbidity and mortality. However, guidelines for oral care to prevent such …

The Care and Management of Bisphosphonate–Associated Osteonecrosis of the Jaw in the Patient with Multiple Myeloma: A Case Study

…, SLE Syme, M Scheper, DS Weikel - American Dental …, 2013 - jdh.adha.org
Purpose: This is a case study of a patient with multiple myeloma presenting with
bisphosphonate–associated osteonecrosis of the jaw after an extraction of tooth #18 while receiving …

[PDF][PDF] Analysis of Clinical, Histologic, and Molecular Characteristics of Proliferative Verrucous Leukoplakia

DR Weikel, A Isaacs, J Basile, DS Weikel, TF Meiller - 2023 - academia.edu
OBJECTIVES/GOALS: This study aims to develop objectively scored histological characteristics
of early oral leukoplakia, which may be correlated with molecular pathways predictive of …

[CITATION][C] Pharmacotherapy for breast cancer: a short primer for the dentist.

RL Wynn, DS Weikel, N Tait, TF Meiller - General Dentistry, 2003 - europepmc.org
Pharmacotherapy for breast cancer: a short primer for the dentist. - Abstract - Europe PMC
Sign in | Create an account https://orcid.org Europe PMC Menu About Tools Developers Help …

MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy

…, W Tissing, JJ Toro, NS Treister, A Vaddi, D Weikel… - Cancer, 2020 - Wiley Online Library
Background Mucositis is a significant toxicity of cancer therapy with numerous systemic
sequelae. The goal of this systematic review was to update the Multinational Association of …

Recognition and management of oral mucosal injury caused by mammalian target of rapamycin inhibitors: a case series

TF Meiller, S Varlotta, D Weikel - Case Reports in Oncology, 2015 - karger.com
… subsequent courses of therapy, the reduction in a patient’s quality of life as a result of oral
pain that … TF Meiller, S. Varlotta, and D. Weikel are investigators on a clinical trial sponsored by …